Add‐on treatment with cenobamate is already effective at low doses in refractory focal epilepsy: A prospective observational study

Documenti analoghi

• Transient global amnesia after the right temporal epilepsy surgery: A case report
  di: Elisa Schütz, et al.
  Pubblicazione: (2024)
• Clinical utility of an ambulatory absence seizure detection system
  di: Nicolas Zabler, et al.
  Pubblicazione: (2025)
• Two‐year outcomes of epicranial focal cortex stimulation in pharmacoresistant focal epilepsy
  di: Andreas Schulze‐Bonhage, et al.
  Pubblicazione: (2025)
• The cenobamate KORK study—A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add‐on lacosamide, perampanel, and brivaracetam
  di: Bernhard J. Steinhoff, et al.
  Pubblicazione: (2024)
• Effectiveness of adjunctive low‐dose clobazam in adults with focal drug‐resistant epilepsy and incomplete response to cenobamate: A real‐world study
  di: Ilaria Ciullo, et al.
  Pubblicazione: (2026)